AMERICAN INTERNATIONAL GROUP, INC. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$31,000
-52.3%
11,309
-6.6%
0.00%
Q4 2021$65,000
-38.1%
12,103
-2.9%
0.00%
-100.0%
Q3 2021$105,000
-32.7%
12,466
-2.3%
0.00%0.0%
Q2 2021$156,000
-39.1%
12,762
+21.1%
0.00%0.0%
Q1 2021$256,000
-24.0%
10,539
+0.3%
0.00%0.0%
Q4 2020$337,000
+3.1%
10,510
-2.8%
0.00%
-50.0%
Q3 2020$327,000
+3.2%
10,812
+43.8%
0.00%0.0%
Q2 2020$317,000
+78.1%
7,517
+5.2%
0.00%
+100.0%
Q1 2020$178,0007,1430.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders